BioGend Therapeutics Co Ltd

ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 34.30 (+1.33%) Dec 26
At Loss
P/B:
4.86
Market Cap:
NT$ 4.26B ($ 129.87M)
Enterprise V:
NT$ 3.64B ($ 110.87M)
Volume:
78.00K
Avg Vol (2M):
159.24K
Trade In:
Volume:
78.00K
At Loss
Avg Vol (2M):
159.24K

BioGend Therapeutics Co Ltd Valuation Measures